newsfilter
← Latest News
Business Wire·

Gemini Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Gemini Therapeutics, Inc. (NASDAQ:GMTX), a clinical stage precision medicine company developing innovative treatments for genetically-defined age-related macular degeneration (AMD), today announced the grant of inducement awards under Gemini's 2021 Indu